The oropharyngeal delivery of interferons: Where are we and where do we need to go?

被引:13
作者
Bocci, V [1 ]
机构
[1] Univ Siena, Inst Gen Physiol, I-53100 Siena, Italy
关键词
D O I
10.1089/107999099313361
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The controversial concept of oral delivery of interferon (IPN) is reviewed in relation to possible mechanisms of action. Although there is a rational basis and some positive clinical results for believing that it may work, problems remain to understand which is the most effective IFN preparation and why. Owing to a minimal cost and lack of toxicity, the oral as well as other unconventional routes of IFN delivery deserve to be evaluated because they may become useful.
引用
收藏
页码:859 / 861
页数:3
相关论文
共 26 条
[1]  
BOCCI V, 1993, LYMPHOKINE CYTOK RES, V12, P21
[2]   ENTERIC ABSORPTION OF HUMAN INTERFERON-ALPHA AND INTERFERON-BETA IN THE RAT [J].
BOCCI, V ;
CORRADESCHI, F ;
NALDINI, A ;
LENCIONI, E .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 34 (1-2) :111-114
[3]  
BOCCI V, 1988, IMMUNOLOGY, V64, P1
[4]   METABOLISM OF PROTEIN ANTICANCER AGENTS [J].
BOCCI, V .
PHARMACOLOGY & THERAPEUTICS, 1987, 34 (01) :1-49
[5]  
BOCCI V, 1992, CRIT REV THER DRUG, V9, P91
[6]   PRODUCTION AND ROLE OF INTERFERON IN PHYSIOLOGICAL CONDITIONS [J].
BOCCI, V .
BIOLOGICAL REVIEWS OF THE CAMBRIDGE PHILOSOPHICAL SOCIETY, 1981, 56 (FEB) :49-85
[8]  
BOCCI V, 1985, J BIOL RESP MODIF, V4, P340
[9]  
BOCCI V, 1991, J BIOL REG HOMEOS AG, V5, P121
[10]   Ingested interferon α suppresses Type I diabetes in non-obese diabetic mice [J].
Brod, SA ;
Malone, M ;
Darcan, S ;
Papolla, M ;
Nelson, L .
DIABETOLOGIA, 1998, 41 (10) :1227-1232